David Liebowitz
Plus aucun poste en cours
Historique de carrière de David Liebowitz
Anciens postes connus de David Liebowitz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2022 | 01/12/2022 |
| VAXART, INC. | Directeur Technique/Scientifique/R&D | 01/01/2012 | 01/05/2018 |
Galileo Pharmaceuticals, Inc.
 Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Directeur Technique/Scientifique/R&D | 01/04/2004 | 16/12/2008 |
Vivaldi Biosciences, Inc.
 Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Directeur Technique/Scientifique/R&D | - | - |
| The University of Chicago | Corporate Officer/Principal | - | - |
Vaxart, Inc. /Old/
 Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | - | - |
| University of Pennsylvania | Corporate Officer/Principal | - | - |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Directeur Technique/Scientifique/R&D | 01/10/2013 | - |
| Corporate Officer/Principal | - | 01/10/2013 | |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/10/2013 | - |
| Corporate Officer/Principal | - | 01/10/2013 |
Formation de David Liebowitz
| Emory University | Graduate Degree |
| The University of Chicago | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 11 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 7 |
| Corporate Officer/Principal | 4 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 4 |
| Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| VAXART, INC. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Health Technology |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Vaxart, Inc. /Old/
Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Retail Trade |
- Bourse
- Insiders
- David Liebowitz
- Expérience
